They aren't just "pandemic stocks." ...

As the pandemic tailwind fades, both Pfizer (PFE) and Moderna (MRNA) have posted financial results that have disappointed investors. Yet, facing the same headwinds, these two companies ...

Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...

Retail investor chatter around vaccine makers Novavax, Moderna, and Pfizer rose on Wednesday, ahead of a closely watched CDC vaccine advisory meeting. At Wednesday’s close, Novavax closed down 0.2% at ...

The excitement of two COVID-19 vaccines with more than 90 percent efficacy is undeniable. In November, both Pfizer and Moderna announced its scientists had developed vaccines with efficacy at or near ...

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

Stocks of COVID-19 vaccine makers take a dive following Washington Post report, while Moderna stresses multiple agencies have backed their safety Stocks of COVID vaccine makers dropped after the ...

Add Yahoo as a preferred source to see more of our stories on Google. Illustration of COVID-19 vaccine vial (Reuters) -Pfizer and Moderna on Wednesday defended their COVID-19 vaccines as having saved ...

Under the deal, Moderna will pay US$950 million (S$1.21 billion) upfront in July 2026. Read more at straitstimes.com. Read more at straitstimes.com.

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Coronavirus disease (COVID-19) vaccination campaign in Ronda LONDON (Reuters) -Pfizer and its German partner BioNTech ...

This ends a drawn out legal battle brought by Genevant and Arbutus against Moderna under a week before the jury trial was set to begin.